Search

Your search keyword '"Nathan, DM."' showing total 459 results

Search Constraints

Start Over You searched for: Author "Nathan, DM." Remove constraint Author: "Nathan, DM."
459 results on '"Nathan, DM."'

Search Results

61. Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study.

63. Preventing type 2 diabetes: what have we learned?

66. New treatments for diabetes.

67. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.

69. Defining the role of common variation in the genomic and biological architecture of adult human height

70. Genetic studies of body mass index yield new insights for obesity biology

71. A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans

72. Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women

73. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

74. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

75. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes

76. Relationship Between Average Glucose Levels and HbA1c Differs Across Racial Groups: A Substudy of the GRADE Randomized Trial.

77. Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.

78. History of the Diabetes Control and Complications Trial and Its Follow-up Epidemiology of Diabetes Interventions and Complications Study: Studies That Changed the Treatment of Type 1 Diabetes.

79. Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).

80. Concussion burden and later-life cardiovascular risk factors in former professional American-style football players.

81. Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial.

82. Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy.

83. Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.

84. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.

85. Effects of metformin and intensive lifestyle interventions on the incidence of kidney disease in adults in the DPP/DPPOS.

86. Diabetes Care Barriers, Use, and Health Outcomes in Younger Adults With Type 1 and Type 2 Diabetes.

88. Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes.

89. Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience.

90. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial.

91. The trial to assess chelation therapy 2 (TACT2): Rationale and design.

92. Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes.

93. Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.

94. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes.

95. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.

96. Association of Traumatic Brain Injury With the Risk of Developing Chronic Cardiovascular, Endocrine, Neurological, and Psychiatric Disorders.

98. Treatment of Diabetes - To Pump or Not to Pump.

99. Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.

100. Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC).

Catalog

Books, media, physical & digital resources